Muscular dystrophy

899,232views

Muscular dystrophy

Watch later

Watch later

Inflammation
Wound healing
Shock: Clinical
Type II hypersensitivity
Type I hypersensitivity
Type IV hypersensitivity
Type III hypersensitivity
Cystic fibrosis
Muscular dystrophy
Metabolic and respiratory alkalosis: Clinical
Metabolic and respiratory acidosis: Clinical
Respiratory alkalosis
Metabolic alkalosis
Hypoxia
Oncogenes and tumor suppressor genes
Hyperplasia and hypertrophy
Atrophy, aplasia, and hypoplasia
Metaplasia and dysplasia
Ischemia
Free radicals and cellular injury
Myocardial infarction
Hypertension
Cushing syndrome
Pheochromocytoma
Coarctation of the aorta
Hypotension
Chronic venous insufficiency
Deep vein thrombosis
Shock
Tetralogy of Fallot
Persistent truncus arteriosus
Ventricular septal defect
Atrial septal defect
Patent ductus arteriosus
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy
Aortic valve disease
Pulmonary valve disease
Tricuspid valve disease
Mitral valve disease
Cor pulmonale
Heart failure
Endocarditis
Myocarditis
Rheumatic heart disease
Pericarditis and pericardial effusion
Atrioventricular block
Bundle branch block
Ventricular tachycardia
Premature ventricular contraction
Ventricular fibrillation
Premature atrial contraction
Atrial flutter
Atrial fibrillation
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Coronary artery disease: Pathology review
Atherosclerosis and arteriosclerosis: Pathology review
Cardiomyopathies: Pathology review
Supraventricular arrhythmias: Pathology review
Heart failure: Pathology review
Valvular heart disease: Pathology review
Ventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Pericardial disease: Pathology review
Hypertension: Pathology review
Shock: Pathology review
Endocarditis: Pathology review
Hyperthyroidism
Hypothyroidism
Hyperparathyroidism
Hypercalcemia
Hypoparathyroidism
Hypocalcemia
Diabetes mellitus
Diabetic nephropathy
Hypopituitarism
Hyperpituitarism
Diabetes insipidus
Hyperthyroidism: Pathology review
Adrenal insufficiency: Pathology review
Hypothyroidism: Pathology review
Diabetes mellitus: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Hypopituitarism: Pathology review
Diabetic retinopathy
Peptic ulcer
Ulcerative colitis
Crohn disease
Bowel obstruction
Gallstone ileus
Abdominal hernias
Inguinal hernia
Small bowel ischemia and infarction
Diverticulosis and diverticulitis
Appendicitis
Jaundice
Cirrhosis
Portal hypertension
Gallstones
Acute cholecystitis
Chronic cholecystitis
Acute pancreatitis
Chronic pancreatitis
Malabsorption syndromes: Pathology review
Inflammatory bowel disease: Pathology review
Esophageal disorders: Pathology review
Diverticular disease: Pathology review
Pancreatitis: Pathology review
Jaundice: Pathology review
Cirrhosis: Pathology review
Iron deficiency anemia
Sideroblastic anemia
Autoimmune hemolytic anemia
Sickle cell disease (NORD)
Aplastic anemia
Megaloblastic anemia
Thrombotic thrombocytopenic purpura
Disseminated intravascular coagulation
Chronic leukemia
Acute leukemia
Non-Hodgkin lymphoma
Hodgkin lymphoma
Polycythemia vera (NORD)
Mastocytosis (NORD)
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Leukemias: Pathology review
Systemic lupus erythematosus
Poststreptococcal glomerulonephritis
DiGeorge syndrome
Hereditary angioedema
Complement deficiency
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Osteoporosis
Spina bifida
Intracerebral hemorrhage
Subarachnoid hemorrhage
Epidural hematoma
Subdural hematoma
Alzheimer disease
Parkinson disease
Hypermagnesemia
Hyperkalemia
Hypokalemia
Hypomagnesemia
Hyponatremia
Hypernatremia
Minimal change disease
Focal segmental glomerulosclerosis (NORD)
Membranoproliferative glomerulonephritis
IgA nephropathy (NORD)
Rapidly progressive glomerulonephritis
Alport syndrome
Kidney stones
Acute pyelonephritis
Chronic pyelonephritis
Chronic kidney disease
Renal artery stenosis
Nephritic syndromes: Pathology review
Renal failure: Pathology review
Nephrotic syndromes: Pathology review
Acute respiratory distress syndrome
Asthma
Emphysema
Chronic bronchitis
Bronchiectasis
Restrictive lung diseases
Sarcoidosis
Pneumonia
Pneumothorax
Pleural effusion
Pulmonary embolism
Pulmonary hypertension
Pulmonary edema
Respiratory distress syndrome: Pathology review
Pneumonia: Pathology review
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review

Transcript

Watch video only

Content Reviewers

With muscular dystrophy, “dys” means bad or difficult, and “troph” means nourish; so muscular dystrophy basically refers to the muscle appearing poorly nourished because of degeneration, which leads to muscle weakness.

Under a microscope, a biopsy of the tissue shows changes in the muscle itself but not in the nerve or neuromuscular junction; this distinguishes muscular dystrophy from other problems that cause muscle weakness as a result of nerve damage, like neuropathies.

Muscular dystrophy is actually a group of disorders, all of which are caused by genetic mutations.

Within that group, dystrophinopathies are the most common, which includes Duchenne muscular dystrophy, or DMD, and Becker muscular dystrophy, both of which result from mutations in the dystrophin gene.

In addition to those two, genetic mutations in other genes are responsible for several dozen other muscular dystrophies, some of which code for proteins that form a protein complex with dystrophin protein.

These other muscular dystrophies, therefore end up causing a lot of the same symptoms as the dystrophinopathies.

Now, the fact that both Duchenne and Becker muscular dystrophy result from mutations in the same dystrophin gene means that they are “allelic disorders,” and when a mutation occurs in dystrophin that’s severe enough to result in no protein at all, for example a nonsense or a frameshift mutation, the result is Duchenne muscular dystrophy, which ends up being the more severe of the two, with symptoms usually presenting by age 5.

On the other hand, mutations that allow for a misshapen protein to form, like missense mutations, lead to Becker muscular dystrophy which is basically a milder form of Duchenne muscular dystrophy that presents later on, usually between age 10 to 20.

Alright so the dystrophin gene is a huge gene on the X-chromosome, that has 79 exons and is over 2 million base pairs in length.

By comparison, most genes have only about 10 exons and are 50 thousand base pairs in length.

More base pairs and more exons mean that there are more chances for mistakes during meiosis, which is when the egg or sperm are being created.

Most of these gene mutations are deletions or duplications of one or more exons, and a small amount are point mutations.

Now males males have one X and one Y chromosome, and females have two X chromosomes.

This means it’s way more common in boys, because they only have one copy of the dystrophin gene, and if that copy’s defective, it’s the only one available to muscle cells, whereas girls with a defective dystrophin gene might have another functional one.

Since this is linked to the X chromosome, both Duchenne and Becker muscular dystrophy are called X-linked recessive.

In females, though, only one X chromosome gets expressed, and the other is inactivated, called X-inactivation or lyonization.

Now if this inactivation’s random, you’d expect about half of the female’s cells to have a functional dystrophin gene and the other half to have a defective dystrophin gene, and these people are typically asymptomatic.

Having said that, if more cells end up with the defective dystrophin gene, and less with the functional one, they can end up being “manifesting carriers,” meaning that they manifest or show some symptoms.

Key Takeaways

Muscular dystrophy is a group of inherited diseases that cause progressive weakness and degeneration of the skeletal muscles that control movement (e.g. Duchenne and Becker muscular dystrophy). Muscular dystrophy is caused by genetic defects that interfere with the production of proteins needed to form healthy muscle. There is currently no cure for muscular dystrophy, physical and occupational therapy, and medications can help manage the symptoms and slow the progression of the disease.